May 26, 2023Biotech, CANADA, clinical trial, FDA, Harvard, Health, IBS, irritable bowel syndrome, massachusetts, News, pain, Psilocybin, psychedelic therapy, Psychedelics, psychotherapy Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment Tryp Therapeutics announced on Wednesday that it had “submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration […]